Latest 3d Printing News

AML3D has successfully commissioned its ARCEMY X system at the Tennessee Valley Authority, marking a significant milestone in its US expansion beyond defence into the energy sector.

Osteopore Limited has won tender bids to supply its innovative orthopaedic implants to two major public hospitals in Vietnam, marking a significant step in its Asia Pacific expansion.

Osteopore Limited has posted a record AUD 835K revenue in Q2 CY25, driven by strong APAC sales and new European market access following EU MDR clearance. The company also advances clinical trials and refreshes key distribution channels.

First Graphene Limited reports over A$1.2 million in annual income, driven by new commercial orders and breakthrough graphene applications in mining safety boots and cement additives.

Osteopore Limited reports a three-fold increase in craniofacial implant sales within a year of signing an exclusive distribution deal with Zimmer Biomet, signaling strong early traction across key global markets.

AML3D has appointed Arc Additive as its UK and European distribution partner, marking a strategic push into key manufacturing and defence markets across Europe. This move follows a successful capital raise and a contract with BAE Systems UK, underpinning AML3D’s growth ambitions.

333D Limited reported a 12% increase in quarterly cash receipts from digital asset management contracts, maintaining steady cash flow despite slight operating cash usage. The company’s annual contract revenue surpassed $970,000, reflecting growing traction in healthcare digital services.

Metal Powder Works has significantly expanded its production capacity and customer base in the June 2025 quarter, while securing strategic partnerships that position it strongly in defence and nuclear sectors.

AML3D has secured a AU$1.2 million order from Austal USA for a portable ARCEMY Small additive manufacturing system, set to enhance the US Navy’s manufacturing capabilities with rapid deployment and flexible use.

Osteopore Limited has gained Swiss market approval for its 3D-printed bioresorbable implants under the EU Medical Device Regulation, completing its European product portfolio and strengthening its partnership with Zimmer Biomet.

Amaero has successfully qualified its C103 and Ti64 metal powders through a collaboration with Auburn University’s NCAME, meeting Velo3D’s standards and paving the way for initial commercial shipments in FY2026.

AML3D has received a pivotal Letter of Intent from the US Navy, outlining plans for additive manufacturing collaboration and significant demand growth through 2030.